Non-Current Assets
Goodwill
Vertex Pharmaceuticals Goodwill remained flat by 0.0% to $1.09B in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $1.09B to $1.09B. Over 5 years (FY 2020 to FY 2025), Goodwill shows relatively stable performance with a 1.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026May 5, 2026
How to read this metric
A significant increase indicates recent M&A activity, while a sudden decrease typically signals an impairment charge due to underperforming acquisitions.
Detailed definition
Goodwill represents the premium paid over the fair market value of net identifiable assets during an acquisition. It ref...
Peer comparison
Standard metric for companies that grow through acquisition; comparable across all industries.
Metric ID:
goodwillHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.00B | $1.00B | $1.00B | $1.00B | $1.00B | $1.08B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +7.3% | +1.2% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +0.0% | +7.3% | +8.6% | +8.6% | +8.6% | +1.2% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
Range$1.00B – $1.09B
CAGR+1.7%
Avg YoY Growth+2.1%
Median YoY Growth+0.0%
Current Streak19+ quarters growth
Goodwill at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's goodwill?
- Vertex Pharmaceuticals (VRTX) reported goodwill of $1.09B in Q1 2026.
- How has Vertex Pharmaceuticals's goodwill changed year-over-year?
- Vertex Pharmaceuticals's goodwill decreased by 0.0% year-over-year, from $1.09B to $1.09B.
- What is the long-term trend for Vertex Pharmaceuticals's goodwill?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's goodwill has grown at a 1.7% compound annual growth rate (CAGR), from $1.00B to $1.09B.
- What does goodwill mean?
- The excess price paid for an acquisition over the fair value of its net assets.